ESNtx005
Rare Cardiomyopathy
PreclinicalActive
Key Facts
About ESN cleer
Australian‑based biotech repurposing orphan drugs for rare cardiomyopathies.
View full company profileRare Cardiomyopathy
Australian‑based biotech repurposing orphan drugs for rare cardiomyopathies.
View full company profile